デノボのコピーナンバー変異と自閉症の強い関連性
Jonathan Sebat1, B Lakshmi, Dheeraj Malhotra
1Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA. sebat@cshl.edu
まとめ
新しく特定された遺伝子変異は,de novoコピー数変異 (CNVs) と呼ばれ,自閉症スペクトル障害 (ASDs) と有意に関連しています. これらの自発的な変異は,自閉症を発症させるための顕著な危険因子です.
科学分野:
- 遺伝学 遺伝学とは
- 発達生物学 発達生物学とは
- 神経科学は神経科学である.
背景:
- 自閉症スペクトル障害 (ASD) は,複雑な神経発達状態です.
- ASDのエチオロジーにおけるde novo遺伝子変異の役割は調査中です.
研究 の 目的:
- デノボコピー数変異 (CNVs) と自閉症スペクトル障害 (ASDs) の関連性を調査する.
- 自発的なゲルムライン変異がASDの危険因子であるかどうかを判断する.
主な方法:
- 比較ゲノムハイブリデーション (CGH) は,患者および対照群におけるCNVを検出するために使用されました.
- 候補地域は,高解像度CGH,父性検査,細胞遺伝学,FISH,およびマイクロサテライトゲノタイプを用いて検証されました.
主要な成果:
- De novo CNVは自閉症と有意に関連していた (P = 0.0005).
- CNVは,散発的な自閉症症例の10%,家族的な症例の3%,対照群の1%で見つかりました.
- de novoで確認されたほとんどのCNVは,微小型のもので,単一の遺伝子を含む異質なゲノム領域に影響を与えました.
結論:
- デノボの生殖系統変異は,ASDの重要な危険因子です.
- これらの発見は,自発的な突然変異が自閉症の遺伝的景観における重要性を強調しています.
関連する概念動画
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Mutations
Overview
Meiosis I
Meiosis is a carefully orchestrated set of cell divisions, the goal of which—in humans—is to produce haploid sperm or eggs, each containing half the number of chromosomes present in somatic cells elsewhere in the body. Meiosis I is the first such division, and involves several key steps, among them: condensation of replicated chromosomes in diploid cells; the pairing of homologous chromosomes and their exchange of information; and finally, the separation of homologous chromosomes by a...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...


